switching from semaglutide to tirzepatide for weight loss results after 8 months on Switching from semaglutide to tirzepatide

Phase 3 trials are underway with potential approval in 2027

You may need to restart titration from a lower dose to avoid GI side effects when re-introducing the drug

It doesn't have a comedogenic rating, but it causes contact sensitisation and inflammation that looks exactly like acne

Parabens and excessive fragrances can also trigger sensitivity, especially when using active ingredients like glutathione

#MASH #MASLD #LiverDisease #MetabolicHealth #GLP1 #Semaglutide #Hepatology #Fibrosis #Cirrhosis #NonInvasiveTesting Laurent Castera, Sven Francque, Eric Lawitz, Ahsan Shoeb, Novo Nordisk, Ahsan, Jesper Clausen, Birgitte Andersen , Anna Bille Larsen, Lise Lotte Gluud To view or add a comment, sign in A 32-year-old with convulsions that won't stop even after two doses of benzodiazepines

03 Research Findings Evidence tier: preclinical animal data, plus human topical cosmetic data